Literature DB >> 12005131

Control of exposure to hexavalent chromium and ozone in gas metal arc welding of stainless steels by use of a secondary shield gas.

John H Dennis1, Michael J French, Peter J Hewitt, Seyed B Mortazavi, Christopher A J Redding.   

Abstract

Previous work has demonstrated that the shield gas composition in gas metal arc welding can have a considerable effect on hexavalent chromium [Cr(VI)] concentration in the fume and on ozone concentrations near the arc. Normally a single shield gas is used. This paper describes a double shroud torch that allows used of concentric shield gases of different compositions. A solid stainless steel wire was used for welding. The double shroud torch used secondary shield gases containing small amounts of the reducing agents NO and C2H4. The Cr(VI) concentration in the fume and ozone concentration at a fixed point relative to the arc were measured and compared with results when using a single shield gas. Use of the reducing agents in secondary shielding using the double shroud torch was found to offer advantages for ozone concentration reduction compared with use in a conventional torch, but this was not found to be an advantage for reducing Cr(VI) concentrations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12005131     DOI: 10.1093/annhyg/mef019

Source DB:  PubMed          Journal:  Ann Occup Hyg        ISSN: 0003-4878


  2 in total

1.  Control of exposure to hexavalent chromium concentration in shielded metal arc welding fumes by nano-coating of electrodes.

Authors:  S P Sivapirakasam; Sreejith Mohan; M C Santhosh Kumar; Ashley Thomas Paul; M Surianarayanan
Journal:  Int J Occup Environ Health       Date:  2018-02-20

2.  Selecting Processes to Minimize Hexavalent Chromium from Stainless Steel Welding: Eight welding processes/shielding gas combinations were assessed for generation of hexavalent chromium in stainless steel welding fumes.

Authors:  M Keane; A Siert; S Stone; B Chen; J Slaven; A Cumpston; J Antonini
Journal:  Weld J       Date:  2012-09       Impact factor: 1.833

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.